Breaking News
Revival Gold Provides Update on the Company’s Annual and Special Meeting
Revival Gold is holding its annual general and special meeting on November 20, 2025, with voting options available electronically due to a Canada Post mail strike. The meeting will cover financial statements, director elections, and stock option plan re-approval.
Latest News
Revival Gold Provides Update on the Company’s Annual and Special Meeting
Revival Gold is holding its annual general and special meeting on November 20, 2025, with voting options available electronically due to a Canada Post mail strike. The meeting will cover financial statements, director elections, and stock option plan re-approval.
2 Quantum Artificial Intelligence (AI) Stocks to Watch Right Now
Quantum computing and generative AI are emerging technologies with potential transformative applications in industries like drug discovery, logistics, and materials science. Google and D-Wave are early leaders exploring quantum computing's potential to revolutionize AI processing and problem-solving.
Beacon Financial Increases International Exposure
Beacon Financial added 21,624 shares of Vanguard Total International Stock ETF (VXUS) worth approximately $2.04 million in Q3 2025, increasing its total position to 126,033 shares valued at $9.26 million, representing a strategic move towards international market diversification.
ATYR Investor Notice: Robbins LLP Reminds Investors of the Securities Fraud Class Action Against aTyr Pharma, Inc.
aTyr Pharma faces a class action lawsuit alleging investors were misled about the efficacy of its drug Efzofitimod in a Phase 3 study for pulmonary sarcoidosis, resulting in an 83.2% stock price decline after announcing the study did not meet its primary endpoint.
Why Protagonist Therapeutics Stock Skyrocketed by Almost 30% Today
Clinical-stage biotech Protagonist Therapeutics saw its stock price jump 29.8% after The Wall Street Journal reported Johnson & Johnson is in discussions to acquire the company, based on their existing collaboration in drug development.
GlobalTech Enters Into Agreement with World Mobile Chain With Plans to Accelerate Blockchain Infrastructure Strategy and Launch WMTx Digital Asset Treasury
GlobalTech Corporation has signed a strategic agreement with World Mobile Chain to deploy blockchain infrastructure and establish a digital asset treasury strategy using WMTx tokens, aiming to enhance operational capabilities and explore digital service innovations.
AI Technology Group Signs Definitive Agreement to Acquire AVM Biotechnology
AI Technology Group has signed a definitive agreement to acquire AVM Biotechnology, a biotech company developing a small-molecule drug (AVM0703) designed to fight cancer by reactivating the body's immune system. The acquisition is supported by a private financing of at least $14 million.
AI Technology Group Signs Definitive Agreement to Acquire AVM Biotechnology
AI Technology Group Inc. has signed a definitive agreement to acquire AVM Biotechnology Inc., a biotech company developing AVM0703, a potential cancer treatment drug currently in Phase 2 clinical trials.
The Capital Link Announces Investigation Into the LuxUrban Story - The $300 Million Hotel Startup That Paid Workers 115% of Their Wages While the City Never Paid Up
LuxUrban Hotels, a $300 million startup, collapsed after providing migrant housing in New York City, facing bureaucratic challenges and unpaid city reimbursements. The company paid workers 115% of wages while awaiting city payments, leading to a Chapter 11 bankruptcy filing and potential legal recovery efforts.
Trump Puts Additional 100% Tariffs On China: Crypto, Stocks Drop
President Trump announced 100% tariffs on Chinese imports starting November 1st, 2025, in response to China's planned export controls on critical materials. The announcement caused significant market volatility, with stocks and cryptocurrencies experiencing sharp declines.